Background – What changed from MDD to MDR? What are the main implications for...
Regulatory
Are Notified Bodies (NB) the bottleneck for the industry under the new MDR?
The new Medical Devices Regulation (EU) 2017/745 (MDR) entered into force in...
Novel Food as a driver for innovation
Under EU regulations, any food that was not consumed “significantly” prior to...
EFSA considers Chia seeds powders as safe
The EFSA Panel on Nutrition, Novel foods and Food Allergens (NDA) just...
EFSA dedicated support for small and medium-sized enterprises (SMEs)
EFSA will extend their dedicated services to applicants from small and...
a&r at Vitafoods Europe 2019
Vitafoods Europe is the perfect place to learn what is happening in the...
Probiotic health claim rejected by EFSA (negative opinion)
EFSA has again rejected the health claim (under article 14) related to...
Novel Food guidance by FSE
Earlier this year, Food Supplements Europe (FSE) released an update of the...
French authority agency (ANSES) releases statement that food supplements for joint health should be avoided by certain at-risk populations
A recent warning by the French Agency for Food, Environmental and Occupational...





